SCHEMBL4182239

SCHEMBL4182239

Cc1ccccc1Nc1ccc(-c2coc3cc(O)ccc3c2=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.65
ALDH1A1 P00352 7/20 0.65
HSD17B10 Q99714 6/20 0.65
HPGD P15428 5/20 0.65
USP2 O75604 2/20 0.65
NPC1 O15118 6/20 0.64
RAB9A P51151 6/20 0.64
SMN1; SMN2 Q16637 5/20 0.64
POLB P06746 2/20 0.64
NPSR1 Q6W5P4 1/20 0.64
MAPT P10636 5/20 0.63
MAOA P21397 4/20 0.63
MAOB P27338 4/20 0.63
TP53 P04637 3/20 0.63
CYP3A4 P08684 3/20 0.63
ALDH2 P05091 3/20 0.63
CYP2D6 P10635 2/20 0.63
CYP2C9 P11712 2/20 0.63
CYP2C19 P33261 2/20 0.63
HDAC6 Q9UBN7 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4191801 0.86 KDM4E (0.67) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL4173475 0.86 KDM4E (0.78) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL4175335 0.80 KDM4E (0.86) KDM4EALDH1A1HSD17B10HPGDNPC1
SCHEMBL2349506 0.79 KDM4E (0.83) KDM4EALDH1A1HSD17B10HPGDUSP2
SCHEMBL29036860 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDUSP2
7-Hydroxy Isoflavone SCHEMBL5803559 0.79 KDM4E (0.94) KDM4EALDH1A1HSD17B10HPGDUSP2
7-Hydroxy Isoflavone SCHEMBL762528 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDUSP2
Daidzein SCHEMBL19814 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDUSP2
Daidzein SCHEMBL21114371 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDUSP2
Daidzein SCHEMBL29374778 0.79 KDM4E (1.00) KDM4EALDH1A1HSD17B10HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192152-A1 Novel Antigiardial Agents and Methods of Use Thereof UNIVERSITY OF MISSISSIPPI 2009-07-30 US disclosed
US-7468445-B2 Antigiardial agents and use thereof UNIVERSITY OF MISSISSIPPI (US) 2008-12-23 US disclosed
US-20060106091-A1 Antigiardial agents and use thereof THE UNIVERSITY OF MISSISSIPPI 2006-05-18 US disclosed
WO-2004014886-A1 ANTIGIARDIAL AGENTS AND USE THEREOF UNIVERSITY OF MISSISSIPPI (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106091-A1 Antigiardial agents and use thereof GPER1, ENPP2, ALPI KDM4E 2433/4885ALDH1A1 2026/4885HSD17B10 1958/4885
US-20090192152-A1 Novel Antigiardial Agents and Methods of Use Thereof ENPP2, GPER1, ALPI KDM4E 2954/4885ALDH1A1 2472/4885HSD17B10 1755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.